Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
Br J Haematol
; 168(1): 69-81, 2015 Jan.
Article
in En
| MEDLINE
| ID: mdl-25196702
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Quinolines
/
Benzamides
/
Leukemia, Myeloid, Chronic-Phase
/
Protein Kinase Inhibitors
/
Aniline Compounds
/
Antineoplastic Agents
/
Nitriles
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2015
Document type:
Article
Affiliation country:
Country of publication: